In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Carol’s Daughter To Grow Retail Presence, Portfolio With $50 Mil. Investment

This article was originally published in The Rose Sheet

Executive Summary

Carol's Daughter plans to expand its distribution footprint, grow into new product categories and give its Web site a makeover in the wake of a $50 million investment in the brand by private equity firm Pegasus Capital Advisors

You may also be interested in...



Catterton Partners/Chrysallis Discusses Future Of Nia 24, Fekkai Investments

Chrysallis's Canyon Ranch skin-care range will launch in spring 2008; meanwhile, the company is preparing to launch the first body product within its Nia 24 line, formulated to address moderate to severe sun damage, and to expand Fekkai hair care to new product categories, the firm says

Profound Beauty Grows Virtual Presence To Avoid Going Mass

"Personalized" hair-care firm Profound Beauty is growing its presence online to attract new customers while preserving its status as a prestige brand

TRIA Beauty Alleges Laser Hair-Removal Center Mislead Customers, Files Suit

Aesthetic device maker TRIA Beauty is bringing a lawsuit against Phoenix Rising Laser, which made "erroneous statements" about TRIA's at-home hair-removal system, according to its July 21 release

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015165

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel